Month: October 2026

Results from the randomized, double-blind, sham-controlled TRANSFORM-AD study published in the Journal of Alzheimer’s Disease, a recognized international peer-reviewed journal

Statistically significant improvement in sleep quality versus sham (p < 0.001) with no serious adverse events; authors describe the study as the first to evaluate high-intensity stimulation for neuropsychiatric symptoms in Alzheimer’s disease

HOUSTON, TX, Oct. 27, 2026 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the publication of a fourth peer-reviewed article reporting results from clinical research on its 15 mA DIFS™ technology in Alzheimer’s disease. The new analysis, published in the Journal of Alzheimer’s Disease, found that 15 mA, 40 Hz stimulation delivered with Nexalin’s device significantly improved sleep quality in patients with mild Alzheimer’s disease compared with sham treatment, with no serious adverse events.

The article, “High-intensity transcranial alternating current stimulation improves sleep quality in patients with mild Alzheimer’s disease: Findings from the TRANSFORM-AD study” (Qiao et al., Journal of Alzheimer’s Disease, 2026; DOI: 10.1177/13872877261492561), was authored by investigators at Xuanwu Hospital, Capital Medical University and the National Center for Neurological Disorders in Beijing, China. It reports a secondary analysis of the TRANSFORM-AD study (ClinicalTrials.gov NCT03920826), a randomized, double-blind, sham-controlled trial whose earlier results, including improvements in cognitive function and hippocampal theta-gamma coupling, were previously published in Alzheimer’s Research & Therapy. The study was funded by the National Key R&D Program of China, and the authors declared no conflicts of interest.

Study Design

Patients with mild Alzheimer’s disease were randomized 1:1 to active stimulation or sham, delivered with Nexalin’s Gen-2 SYNC 15 mA device. The active group received 30 one-hour sessions of 40 Hz stimulation at a peak-to-peak amplitude of 15 mA, administered twice daily over 15 consecutive days with electrodes placed on the forehead and bilateral mastoids. The sham group followed an identical protocol with zero current output; active and sham devices were indistinguishable in appearance and sensation, and participants, caregivers, outcome assessors and research nurses remained blinded throughout. Sleep quality, measured by the Pittsburgh Sleep Quality Index (PSQI), was the pre-specified primary outcome of the analysis, with anxiety, depression and quality of life evaluated as exploratory outcomes. Of the 46 randomized participants, 43 (20 active, 23 sham) completed baseline and post-treatment assessments.

Key Findings

• Significant improvement in sleep quality. After adjustment for baseline scores, patients receiving 15 mA stimulation had PSQI scores 2.34 points lower than the sham group at the end of treatment (95% CI, −3.63 to −1.05; p < 0.001), where lower scores indicate better sleep.
• Within-group change. Mean PSQI in the active group fell from 9.65 to 6.35, a reduction of 3.30 points, or approximately 34%, compared with a reduction of 0.52 points in the sham group.
• Robust across sensitivity analyses. The treatment effect remained significant after additional adjustment for age, sex, education and baseline cognitive scores (−2.56 points; p < 0.001) and in a mixed-model repeated-measures analysis (−2.78 points; p < 0.001).
• Favorable safety and tolerability. No serious adverse events were observed in either group. One patient in the active group reported a transient tingling sensation during the first two sessions, and one patient in the sham group reported transient itching at the first session.
• Exploratory outcomes and limitations. The analysis did not provide conclusive evidence of effects on anxiety, depression or quality of life, which were evaluated as exploratory outcomes. The authors note that participants’ low baseline anxiety and depression scores may account for these findings and call for larger, adequately powered trials. They also note that sleep quality was measured with a self-reported questionnaire, that the duration of the effect after treatment is not yet known, and that blinding integrity was not formally assessed.

Why Sleep Matters in Alzheimer’s Disease

According to the authors, approximately 45% of individuals with Alzheimer’s disease experience sleep-related problems such as insomnia, sleep fragmentation and excessive daytime sleepiness, and a growing body of evidence supports a bidirectional relationship between sleep disturbance and Alzheimer’s pathology. According to the Alzheimer’s Association, an estimated 7.4 million Americans age 65 and older are living with Alzheimer’s disease in 2026. The authors also propose, as a hypothesis for future research, that improved sleep could be associated with enhanced clearance of pathological proteins such as amyloid-beta, which they note were not measured in this study. The investigators describe the study as the first to evaluate high-intensity stimulation for the management of neuropsychiatric symptoms in Alzheimer’s disease, and conclude that the therapy “has potential as an effective therapeutic approach for mild AD patients with sleep disorder.”

The authors also highlight why intensity matters. Conventional transcranial alternating current stimulation operates at 1–4 mA and, in their words, “predominantly modulate[s] superficial cortical regions,” whereas the 15 mA protocol used in TRANSFORM-AD “occupies a unique position” in the field because of its “capacity to deliver electrical currents directly to deep brain structures” such as the hippocampus, insula and amygdala, which we believe is the same deep-brain mechanism that underpins Nexalin’s DIFS™ platform. The authors further note that this approach is portable and suitable for home-based administration, while acknowledging a trade-off in spatial focality. They also cite prior research showing that 15 mA, 77.5 Hz stimulation, the approach used in Nexalin’s insomnia program, improved sleep quality in patients with chronic insomnia.

Management Commentary

“This fourth peer-reviewed publication on our 15 mA waveform in Alzheimer’s disease extends the story from cognition and brain networks to one of the most burdensome symptoms families face every day: sleep,” said Mark White, Chief Executive Officer of Nexalin Technology. “A statistically significant improvement in sleep quality, achieved with a non-invasive, drug-free, 15-day course of treatment and no serious adverse events, is exactly the kind of evidence we believe will matter to physicians, patients and regulators.”

“Each of these four publications, in Alzheimer’s Research & Therapy, Radiology and now two in the Journal of Alzheimer’s Disease, reports results from blinded, sham-controlled research, including multiple analyses of the same TRANSFORM-AD study, and together we believe they point to the same conclusion: delivering 15 mA of current to deep brain structures produces measurable changes in how the Alzheimer’s brain functions,” Mr. White continued. “As we plan our U.S. pilot study following our Q-Submission meeting with the FDA, we believe Nexalin is building a growing published evidence base in non-invasive brain stimulation for Alzheimer’s disease.”

A Growing Body of Peer-Reviewed Evidence in Alzheimer’s Disease and Dementia

Today’s publication joins three previously announced peer-reviewed articles reporting results from clinical research on Nexalin’s 15 mA technology in Alzheimer’s disease and dementia:

• Alzheimer’s Research & Therapy: results of the TRANSFORM-AD randomized controlled trial, reporting improvements in MMSE and MoCA cognitive scores and enhanced hippocampal theta-gamma coupling after 30 sessions of 15 mA, 40 Hz stimulation.
• Journal of Alzheimer’s Disease: resting-state fMRI analysis reporting increased regional brain activity and synchronization in the left middle frontal gyrus and right parahippocampal gyrus following treatment.
• Radiology (flagship journal of the Radiological Society of North America): randomized, sham-controlled trial reporting improved cognition together with enhanced hippocampal-cortical connectivity, with cognitive gains correlating with imaging findings.
• Journal of Alzheimer’s Disease (today’s announcement): secondary analysis of TRANSFORM-AD reporting a statistically significant improvement in sleep quality versus sham, with no serious adverse events.

Nexalin has completed a Q-Submission meeting with the U.S. Food and Drug Administration (FDA) for its Gen-2 SYNC 15 mA device in Alzheimer’s disease, in which the Company discussed the potential use of the De Novo classification pathway and received feedback that provides a clear framework for a planned U.S. pilot study. The Gen-2 SYNC device is approved in China, Brazil and Israel. The published Alzheimer’s disease evidence base, together with peer-reviewed publications in insomnia (Psychotherapy and Psychosomatics) and ADHD (Molecular Psychiatry), supports the Company’s mood-military-memory clinical business plan and its goal of becoming the global leader in non-invasive stimulation of the brain for the treatment of mental health conditions, including Alzheimer’s disease and dementia.

The full article is available at https://doi.org/10.1177/13872877261492561.

About Nexalin Technology, Inc.

Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic. Nexalin’s medical devices are non-invasive and designed to be undetectable to the human body. Nexalin products are developed to provide relief to those afflicted with mental health issues using frequency based bioelectronic medical technology. Nexalin believes its neurostimulation medical devices can penetrate structures deep in the mid-brain that are associated with mental health disorders. Nexalin’s next-generation devices use a deeper-penetrating waveform designed to enhance patient response with a favorable tolerability profile, which continues to be evaluated in clinical studies. The Nexalin Gen-2 15 milliamp neurostimulation device has been approved in China, Brazil and Israel. Additional information about the Company is available at: https://nexalin.com/.

FORWARD-LOOKING STATEMENTS

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995 (the “PSLRA”). These forward-looking statements relate to future events, future performance, or management’s current expectations, beliefs, assumptions, plans, estimates, intentions, or projections relating to the future, and are not guarantees of future performance. Any statements that are not statements of historical fact, or that refer to expectations, projections, or other characterizations of future events or circumstances (including, without limitation, statements containing the words “believes,” “expects,” “anticipates,” “plans,” “intends,” “will,” “may,” “could,” “should,” “would,” “designed to,” “positioned to,” “potential,” “targeted,” “seeking,” “continues,” “strategy,” “opportunity,” “estimates,” “projects,” “forecasts,” “predicts,” “outlook,” “guidance,” or similar expressions, or the negative of such terms), are forward-looking statements. The Gen-2 SYNC device is investigational in the United States and has not been cleared, approved or otherwise authorized by the FDA for any indication. The TRANSFORM-AD study was an investigator-initiated study conducted at a single site; its results may not be replicated in other studies, and the findings described in this press release have not been reviewed by the FDA.

Forward-looking statements in this press release include, but are not limited to, statements regarding: the clinical significance and implications of the published study results; the expected relevance of the published evidence to physicians, patients and regulators; the potential of the Company’s technology to treat sleep disturbance, cognitive impairment or other symptoms of Alzheimer’s disease and dementia; the Company’s planned U.S. pilot study in Alzheimer’s disease, the Company’s interpretation of FDA feedback received in its Q-Submission meeting, and its pursuit of a De Novo regulatory pathway and FDA marketing authorization; the Company’s beliefs regarding the ability of its devices to penetrate deep brain structures and the anticipated patient response and tolerability of its devices; and the Company’s goal of becoming a global leader in non-invasive brain stimulation. These statements are based on Nexalin’s current expectations and assumptions as of the date hereof and are subject to significant risks, uncertainties, and other factors, many of which are beyond the Company’s control, that could cause actual results to differ materially from those expressed or implied.

Such risks include, but are not limited to: the Company’s need for additional capital and its ability to continue as a going concern; the Company’s ability to maintain its Nasdaq listing; the possibility that results from secondary analyses, single-site or investigator-initiated studies will not be replicated in larger or controlled trials; the risk that sleep-quality results, which were based on a self-reported questionnaire in 43 evaluable participants and for which the duration of effect after treatment is unknown, may not be durable or reproducible; the risk that the FDA may not accept clinical data generated outside the United States, including the TRANSFORM-AD study conducted in China; the risk that feedback received through the FDA Q-Submission process is non-binding and that the FDA may not agree that the De Novo pathway is available for the Company’s device or with the design of the planned U.S. pilot study; delays in clinical trial enrollment or completion, unfavorable clinical results, and the Company’s reliance on third parties to conduct its clinical trials; the risk that the FDA may require additional studies, different endpoints or additional data, or may not grant marketing authorization; the risk that the Company’s devices may not demonstrate the anticipated efficacy or may be associated with adverse events; market acceptance of the Company’s products; the Company’s ability to protect and enforce its intellectual property; competition; and the trading price of the Company’s common stock and general market conditions. Additional risks and uncertainties are described under the heading “Risk Factors” in the Company’s most recent Annual Report on Form 10-K for the year ended December 31, 2025, and in the Company’s subsequent Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and other filings the Company makes from time to time with the U.S. Securities and Exchange Commission (the “SEC”), available free of charge at www.sec.gov. Readers are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to update any forward-looking statement, except as required by law.

Contact:
Crescendo Communications, LLC
Tel: (212) 671-1020
Email: NXL@crescendo-ir.com

Broadcom Fixes 89 New Open Source Vulnerabilities in TrueSource Spring Enterprise, Reaching 408 Total in 2026

PALO ALTO, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) — Broadcom Inc. (NASDAQ: AVGO), a global technology leader that designs, develops, and supplies semiconductor and infrastructure software solutions, today shipped fixes for 89 novel vulnerabilities in TrueSource Spring Enterprise to its critical infrastructure customers and others who qualify for early access, ahead of public disclosure. This brings the total number of vulnerabilities fixed across TrueSource offerings to 408.

Patches only secure an environment once deployed. To close that gap, Spring Enterprise adds TrueSource Hub to help enterprises assess application exposure, prioritize critical fixes, and track status. Additionally, build plugins for Application Advisor automate patching within existing Maven or Gradle workflows, generating update pull requests to streamline merging approved fixes.

A sustained investment in open source security

Building on its June 2026 open source commitment, Broadcom uses Frontier AI scanning and advanced research to find and fix vulnerabilities. TrueSource Spring Enterprise delivers simultaneous fixes across all supported versions, giving legacy releases immediate access, while providing security-only patches for current versions to speed deployment. Detailed vulnerability information will be published when fixes reach the community and CVEs are issued.

Scale & Impact: Reaching a massive footprint of downloads of Spring and Reactor libraries in 2026, Broadcom engineers fixed 406 new vulnerabilities, delivered over 1,090 fixes (including 798 backports), reviewed 2,600+ reports, and filtered out 3,000+ false alarms.

Key High/Critical Broadcom Fixes Earlier This Year:

• Spring (June): Fixed a remote code execution vulnerability (CVE-2026-41855, CVSS 8.1) across four supported lines simultaneously.
• Netty Dependency (June): Discovered a DNS redirection vulnerability (CVE-2026-47691, CVSS 10.0) and addressed with the community maintainers and fixed for all supported Spring versions.
• RabbitMQ (July): Fixed a credential forgery vulnerability (CVE-2026-67404, CVSS 9.2) across four supported lines at once.

“Security isn’t a one-time initiative; it’s an ongoing commitment. In June, we pledged to identify and resolve Spring vulnerabilities faster than ever, and today’s release demonstrates our continued momentum,” said Purnima Padmanabhan, general manager, Tanzu Division, Broadcom. “Our customers receive critical fixes early in a deployable format, with complete visibility into where patches belong and confirmation when they land. Crucially, fixes are contributed back to the open source community—because open source remains resilient only when businesses actively invest in ecosystem health.”

See it, prioritize it, fix it, prove it

Most enterprises know they run open source. Few can say exactly which applications run which versions, which are out of support, and which need a fix published this morning. TrueSource Spring Enterprise closes that gap with four capabilities that work together:

• Assess every repository. TrueSource Hub connects to an organization’s code repositories and shows the security state of the open source components every application depends on, across Java, Python, and JavaScript libraries, container images, and data services, along with its patch status, in a live view rather than a one-time audit.
• Prioritize the fixes that matter. When Broadcom publishes a fix, Hub shows which applications need it and how exposed they are, so security and engineering leaders can direct effort to the applications that carry the most risk. TrueSource works with the vulnerability scanners that teams already use. Snyk, for example, is actively partnering with Broadcom so that customers can recognize Broadcom-patched Spring versions as fixed, with the goal of reducing unnecessary alerts and keeping teams from chasing alerts for already-resolved vulnerabilities.
• Apply patches in the build. For Spring applications, Spring Application Advisor plugins integrate directly into existing Maven and Gradle builds. Fixes and version upgrades arrive as reviewable pull requests built on deterministic recipes verified by TrueSource engineers. Additionally, the new integration with JFrog Zero-Touch Remediation delivers instant protection. By automatically delivering verified, backward-compatible TrueSource fixes to builds, security teams can stop waiting on manual pull requests and dependency overrides – keeping software secure with zero friction.
• Prove it through pipeline audits. Every build records its source and the libraries it contains and reports that to TrueSource, so security leaders can show their boards and leadership exactly which libraries shipped and where each fix was applied.

The TrueSource portfolio

TrueSource by Broadcom is Broadcom’s portfolio of enterprise open source software, verified by engineers and delivered from one trusted source. It has three offerings:

• TrueSource Spring Enterprise for the Spring framework Broadcom maintains, with CVE-only patches, the security fix and nothing else, delivered for every supported version at the same time so teams can apply them without an upgrade, plus the tooling announced today.
• TrueSource Trusted Artifacts for verified open source libraries in Java, Python, and JavaScript, and the Secure Images catalog of container images, covering the middleware, runtimes, and backing services applications depend on.
• TrueSource Data Services for the data engines applications rely on: PostgreSQL, MySQL, Valkey, and RabbitMQ, with self-service provisioning, fleet management across environments, and enterprise support for the engines themselves, including prescribed high availability and disaster recovery.

Availability

TrueSource Spring Enterprise, featuring TrueSource Hub and build plugins, is generally available today. Its 87 fixes are accessible immediately to early-access and critical infrastructure customers, with public CVE release to follow. TrueSource Spring Enterprise, Trusted Artifacts, and Data Services are offered via tiered site licensing. Learn more at https://www.broadcom.com/products/software/truesource.

About Broadcom

Broadcom Inc. (NASDAQ: AVGO) is a technology leader that designs, develops, and supplies semiconductors and infrastructure software for global organizations’ complex, mission-critical needs. Broadcom combines long-term R&D investment with superb execution to deliver the best technology, at scale. Broadcom is a Delaware corporation headquartered in Palo Alto, CA. For more information, visit www.broadcom.com.

Broadcom and the pulse logo are among the trademarks of Broadcom. Postgres and PostgreSQL are registered trademarks of the PostgreSQL Community Association of Canada. MySQL is a registered trademark of Oracle Corporation. Valkey is a trademark of The Linux Foundation. All other trademarks are the property of their respective owners. Broadcom is not affiliated with, endorsed by, or sponsored by any of the foregoing organizations.

Media contact

John D’Avolio

Tanzu Division, Broadcom

+1.503.308.3096

john.davolio@broadcom.com

SANTA CRUZ, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) — West Coast Community Bancorp (Nasdaq: WCCB) (“Bancorp” or the “Company”), the parent company of West Coast Community Bank (the “Bank”), announced unaudited net income for the quarter ended September 30, 2026, of $16.7 million, compared to $12.2 million for the second quarter of 2026, representing an increase of 37.7%. Net income was $43.9 million and $36.7 million for the nine months ended September 30, 2026, and 2025, respectively, representing an increase of 19.7%. Diluted earnings per share (“EPS”) for the third quarter of 2026 were $1.59 compared to $1.16 for the second quarter of 2026. Diluted EPS was $4.17 and $3.45 for the nine months ended September 30, 2026, and 2025, respectively.

Earnings for the third quarter of 2026 reflected higher net interest income stemming from growth in all categories of average interest-earning assets, including growth in loans, as well as the recognition of a $920 thousand income tax benefit associated with the Bank’s purchase of renewable energy tax credits at a discount during the third quarter. This income tax benefit increased both basic and diluted EPS by approximately $0.09 during the three and nine months ended September 30, 2026. Earnings for the third quarter also benefited from the absence of $1.8 million of accelerated purchase discount accretion, which was recorded in the second quarter of 2026, and was associated with the redemption of higher-cost subordinated debentures assumed in the merger with 1^st Capital Bancorp in 2024 (“sub debt redemption”). The sub debt redemption reduced both basic and diluted EPS by approximately $0.12 during the second quarter as well as for the nine months ended September 30, 2026.

“We delivered record quarterly earnings, marked by higher net interest income driven by solid loan growth – particularly by our San Luis Obispo County team – and overall higher average interest-earning assets funded through healthy deposit growth during the quarter,” said Krista Snelling, Chairman and Chief Executive Officer of West Coast Community Bancorp. “This quarter saw tremendous momentum across the business, including our expansion into Silicon Valley and the Peninsula and our Nasdaq listing. We continue to execute on our strategic priorities and growth initiatives, such as hiring our Private Banking team and opening new branches.”

As previously announced on October 19, 2026, the Bancorp Board of Directors declared a quarterly cash dividend of $0.29 per common share, reflecting a $0.04 per share increase over the previous quarterly dividend. This dividend is payable on or about November 6, 2026, to shareholders of record as of November 2, 2026. “Increasing the dividend reflects the strength of our business, the confidence of our Board in our capacity for future growth and a commitment to rewarding our shareholders,” added Snelling.

Financial Highlights

	As of or for the Three Months Ended												For the Nine Months Ended
	September 30,				June 30,				September 30,				September 30,				September 30,
	2026				2026				2025				2026				2025
	(Dollars in thousands, except per share data)
Selected Financial Data
Net income	$	16,740			$	12,161			$	12,061			$	43,888			$	36,657
Net interest margin		5.18	%			4.90	%			5.26	%			5.06	%			5.27	%
Taxable equivalent net interest margin (a)		5.20	%			4.92	%			5.28	%			5.08	%			5.29	%
Cost of funds (b)		1.31	%			1.59	%			1.37	%			1.39	%			1.37	%
Efficiency ratio (c)		42.31	%			46.24	%			43.13	%			43.97	%			44.88	%
Return on:
Average assets		2.21	%			1.69	%			1.73	%			2.01	%			1.82	%
Average equity		16.44	%			12.32	%			13.16	%			14.84	%			13.89	%
Average tangible equity (d)		20.20	%			15.47	%			17.05	%			18.47	%			18.17	%
Allowance for credit losses on loans / gross loans		1.57	%			1.55	%			1.74	%
Noninterest-bearing deposits to total deposits		39.00	%			39.74	%			43.46	%
Gross loan-to-deposit ratio		91.46	%			90.04	%			87.32	%
Percent growth in loans		2.89	%			2.35	%			0.82	%			7.57	%			4.01	%
Percent growth in deposits		1.29	%			1.96	%			7.79	%			3.15	%			5.44	%
Capital Ratios
Tier 1 leverage ratio		12.07	%			12.11	%			11.37	%
Common equity tier 1 risk-based capital ratio		13.33	%			13.22	%			12.93	%
Tier 1 risk-based capital ratio		13.33	%			13.22	%			12.93	%
Total risk-based capital ratio		14.59	%			14.47	%			14.65	%
Tangible common equity ratio (e)		11.69	%			11.67	%			10.95	%
Share and Per Share Data
Basic earnings per share (“EPS”)	$	1.61			$	1.17			$	1.15			$	4.23			$	3.49
Diluted EPS	$	1.59			$	1.16			$	1.14			$	4.17			$	3.45
Book value per share	$	38.25			$	37.90			$	34.97
Tangible book value per share (f)	$	32.46			$	32.01			$	28.81
(a) Net interest margin is calculated by dividing annualized taxable equivalent net interest income, a non-GAAP measure, by period average interest-earning assets. Interest income on tax-exempt securities and loans are presented on a taxable-equivalent basis using the federal statutory rate of 21 percent. Please see “Non-GAAP Financial Measures” below.
(b) Cost of funds is computed by dividing annualized interest expense by the sum of period average deposits and borrowings.
(c) Efficiency ratio, a non-GAAP measure, equals total noninterest expenses divided by the sum of net interest income and noninterest income. Please see “Non-GAAP Financial Measures” below.
(d) Return on average tangible equity, a non-GAAP measure, is calculated by dividing annualized net income (adjusted for the after-tax amortization of intangible assets) by average tangible equity for the period. Tangible common equity is defined in note (f) below. In this release we also may refer to tangible common equity as tangible equity. Please see “Non-GAAP Financial Measures” below.
(e) Tangible common equity ratio, a non-GAAP measure, is calculated by dividing tangible common equity, as defined in note (f) below, by assets less goodwill and other intangible assets. Please see “Non-GAAP Financial Measures” below.
(f) Tangible common equity, a non-GAAP measure, equals total shareholders’ equity less goodwill and other intangible assets. Tangible book value per share, a non-GAAP measure, divides tangible common equity by the number of shares outstanding at the period end. Please see “Non-GAAP Financial Measures” below.

• Total loans, net of unaccreted purchase discount and deferred fees and costs, were $2.34 billion at September 30, 2026, compared to $2.27 billion at June 30, 2026, representing an increase of $65.6 million, or 2.9%. Loan growth was most notable in revolving commercial lines, especially in agriculture-related businesses sourced from our San Luis Obispo County team.
• Taxable equivalent net interest margin, a non-GAAP measure, was 5.20% and 4.92% for the quarters ended September 30, 2026, and June 30, 2026, respectively. The quarter-over-quarter increase is largely attributed to the absence of the sub debt redemption that occurred in the second quarter of 2026. Excluding the impact of sub debt redemption, the adjusted taxable equivalent net interest margin, a non-GAAP measure, was 5.19% for the second quarter of 2026. Please see “Non-GAAP Financial Measures” below.
• The cost of funds was 1.31% and 1.59% for the quarters ended September 30, 2026, and June 30, 2026, respectively. The quarter-over-quarter decrease in the cost of funds is attributed to the absence of the sub debt redemption that occurred in the second quarter. Excluding the impact of the sub debt redemption, the adjusted cost of funds, a non-GAAP measure, was approximately 1.29% for the second quarter of 2026. Please see “Non-GAAP Financial Measures” below.
• The efficiency ratio, a non-GAAP measure, was 42.31% and 46.24% for the quarters ended September 30, 2026, and June 30, 2026, respectively. The decrease in the efficiency ratio for the third quarter of 2026 is largely attributed to the absence of $1.8 million in accelerated accretion associated with the sub debt redemption in the second quarter, as well as higher net interest income in the third quarter driven by growth in average interest-earning assets. Excluding the impact of the sub debt redemption, the adjusted efficiency ratio, a non-GAAP measure, was 42.31% and 43.91% for the quarters ended September 30, 2026, and June 30, 2026, respectively. Please see “Non-GAAP Financial Measures” below.
• Return on average assets (“ROAA”) was 2.21% and 1.69% for the quarters ended September 30, 2026, and June 30, 2026, respectively. Excluding the benefit on the purchase of transferable renewable energy tax credits in the third quarter and the impact of accelerated accretion on the sub debt redemption that occurred in the second quarter, adjusted ROAA, a non-GAAP measure, was 2.08% and 1.87% for the quarters ended September 30, 2026, and June 30, 2026, respectively. Please see “Non-GAAP Financial Measures” below.
• Return on average equity (“ROAE”) was 16.44% and 12.32% for the quarters ended September 30, 2026, and June 30, 2026, respectively. ROAE was favorably impacted in the third quarter by the absence of accelerated accretion on the sub debt redemption that occurred in the second quarter and the benefit on the purchase of transferable renewable energy tax credits. Excluding these items, adjusted ROAE, a non-GAAP measure, was 15.53% and 13.62% for the quarters ended September 30, 2026, and June 30, 2026, respectively. Please see “Non-GAAP Financial Measures” below.
• Return on average tangible equity (“ROATE”), a non-GAAP measure, was 20.20% and 15.47% for the quarters ended September 30, 2026, and June 30, 2026, respectively. Excluding the benefit on the purchase of transferable renewable energy tax credits in the third quarter and accelerated accretion on the sub debt redemption that occurred in the second quarter, adjusted ROATE, a non-GAAP measure, was 19.13% and 17.01% for the quarters ended September 30, 2026, and June 30, 2026, respectively. Please see “Non-GAAP Financial Measures” below.
• Total provision for credit losses on loans and unfunded loan commitments was $7 thousand for the third quarter of 2026, compared to a provision for credit losses of $1.5 million for the second quarter. The quarter-over-quarter decrease is largely attributed to the full recovery of a previously substantially charged-off loan in the amount of $1.2 million, favorable changes in economic forecasts and qualitative factors used in the allowance for credit losses (“ACL”) model. These were partially offset by the impact of loan growth and the change in the mix of loans during the quarter as well as an increase in the allowance for certain individually evaluated loans.
• Total assets were $2.98 billion at September 30, 2026, compared to $2.95 billion at June 30, 2026, representing an increase of $38.4 million, or 1.3%, from June 30, 2026. The quarter-over-quarter increase in total assets is largely attributed to a $65.6 million increase in total loans.
• Total deposits were $2.56 billion at September 30, 2026, compared to $2.52 billion at June 30, 2026, representing an increase of $32.5 million, or 1.3%, from June 30, 2026. The increase in deposits during the third quarter was largely driven by the establishment of new client relationships.
• Bancorp’s regulatory capital ratios exceeded applicable minimum capital adequacy requirements, and the Bank continued to meet the regulatory capital thresholds necessary to be categorized as well capitalized under the prompt corrective action framework. Bancorp’s total risk-based capital ratio was 14.59% and 14.47% at September 30, 2026, and June 30, 2026, respectively. The tangible common equity ratio, a non-GAAP measure, was 11.69% and 11.67% at September 30, 2026, and June 30, 2026, respectively. Please see “Non-GAAP Financial Measures” below.
• Tangible book value per share, a non-GAAP measure, was $32.46 and $32.01 at September 30, 2026, and June 30, 2026, respectively. Please also see “Non-GAAP Financial Measures” below.
• Primary liquidity ratio, defined as cash and cash equivalents, deposits held in other banks and unpledged available for sale (“AFS”) securities as a percentage of total assets, was 11.7% and 13.0% at September 30, 2026, and June 30, 2026, respectively.

Net Interest Income and Net Interest Margin

Net interest income was $37.1 million for the third quarter of 2026, representing an increase of $4.0 million, or 12.0%, from $33.1 million for the second quarter of 2026. The quarter-over-quarter increase in net interest income is attributed to growth in average interest-earning assets during the third quarter and the absence of $1.8 million in accelerated accretion associated with the sub debt redemption that occurred in the second quarter. The increase in interest-earning assets is attributed to growth in loan balances during the quarter as well as higher average balances of investment securities and interest-earning cash. These increases were funded in part by higher average deposit balances during the quarter.

The taxable equivalent net interest margin, a non-GAAP measure, was 5.20% for the third quarter of 2026, compared to 4.92% for the second quarter, or 5.19%, on an adjusted basis when excluding the impact of the sub debt redemption, a non-GAAP measure. The modest quarter-over-quarter increase in the adjusted taxable equivalent net interest margin can be attributed to slightly higher overall yields on average interest-earning assets, including a seven-basis-point increase in the average yield on loans during the third quarter. This was partially offset by a slight increase in the adjusted cost of funds, a non-GAAP measure, during the third quarter that can be attributed to growth in money market deposits, coupled with slightly higher overall rates on deposits during the third quarter. The cost of funds for the third quarter of 2026 was 1.31%, compared to 1.59% for the second quarter, or 1.29% on an adjusted basis when excluding the impact of the sub debt redemption in the second quarter, a non-GAAP measure. Please see “Non-GAAP Financial Measures” below.

The following tables compare interest income, average interest-earning assets, interest expense, average interest-bearing liabilities, net interest income, net interest margin and cost of funds for each period presented:

	For the Three Months Ended
	September 30, 2026									June 30, 2026									September 30, 2025
	Average Balance			Interest Income / Expense			Avg Yield / Cost			Average Balance			Interest Income / Expense			Avg Yield / Cost			Average Balance			Interest Income / Expense			Avg Yield / Cost
	(Dollars in thousands)
ASSETS
Interest-earning cash	$	149,017		$	1,386		3.69	%		$	98,211		$	893		3.65	%		$	116,056		$	1,284		4.39	%
Investment securities (1)		394,507			3,797		3.82	%			382,863			3,530		3.70	%			385,235			3,374		3.47	%
Loans (1) (2)		2,300,973			40,659		7.01	%			2,233,133			38,631		6.94	%			2,109,593			38,356		7.21	%
Total interest-earning assets (1)		2,844,497			45,842		6.39	%			2,714,207			43,054		6.36	%			2,610,884			43,014		6.54	%
Noninterest-earning assets		167,307									165,372									161,773
Total assets	$	3,011,804								$	2,879,579								$	2,772,657
LIABILITIES
Interest-bearing demand deposits	$	243,538			606		0.99	%		$	247,226			571		0.93	%		$	248,684			665		1.06	%
Money market deposits		1,030,064			6,762		2.60	%			945,898			6,043		2.56	%			785,520			5,787		2.92	%
Savings deposits		170,096			365		0.85	%			160,143			306		0.77	%			181,256			441		0.97	%
Time certificates of deposits		136,962			819		2.37	%			139,526			844		2.43	%			152,992			1,125		2.92	%
Subordinated debt		—			—		—	%			7,794			1,991		102.46	%			11,052			229		8.22	%
Total interest-bearing liabilities		1,580,660			8,552		2.15	%			1,500,587			9,755		2.61	%			1,379,504			8,247		2.37	%
Noninterest-bearing deposits		999,936									959,162									1,008,555
Noninterest-bearing liabilities		27,110									23,876									20,913
Total liabilities		2,607,706									2,483,625									2,408,972
EQUITY		404,098									395,954									363,685
Total liabilities and equity	$	3,011,804								$	2,879,579								$	2,772,657
Taxable equivalent net interest income and margin (1)				$	37,290		5.20	%					$	33,299		4.92	%					$	34,767		5.28	%
GAAP net interest income and margin				$	37,110		5.18	%					$	33,138		4.90	%					$	34,634		5.26	%
Cost of funds							1.31	%								1.59	%								1.37	%
(1) Interest income on investment securities, interest income on loans, net interest income and net interest margin are presented here on a taxable equivalent basis, using the statutory federal income tax rate of 21 percent, and are non-GAAP financial measures. Please see “Non-GAAP Financial Measures” below.
(2) Average balances on loans outstanding include nonaccrual loans, unamortized net deferred loan fees/costs and unaccreted purchase discount on acquired loans. The amortization of net loan origination fees and accretion of purchase discount on acquired loans are included in interest income on loans.

		For the Nine Months Ended
		September 30, 2026									September 30, 2025
		Average Balance			Interest Income / Expense			Avg Yield / Cost			Average Balance			Interest Income / Expense			Avg Yield / Cost
		(Dollars in thousands)
ASSETS
Interest-earning cash		$	132,851		$	3,646		3.67	%		$	52,920		$	1,734		4.38	%
Investment securities (1)			388,635			10,802		3.72	%			381,978			9,819		3.44	%
Loans (1) (2)			2,237,480			116,423		6.96	%			2,096,800			112,354		7.16	%
Total interest-earning assets (1)			2,758,966			130,871		6.34	%			2,531,698			123,907		6.54	%
Noninterest-earning assets			162,760									162,157
Total assets		$	2,921,726								$	2,693,855
LIABILITIES
Interest-bearing demand deposits		$	247,187			1,750		0.95	%		$	251,187			1,951		1.04	%
Money market deposits			967,283			18,549		2.56	%			736,528			15,660		2.84	%
Savings deposits			166,115			1,017		0.82	%			174,706			1,127		0.86	%
Time certificates of deposits			140,819			2,590		2.46	%			159,616			3,699		3.10	%
Short-term borrowings			—			—		—	%			12,317			412		4.47	%
Subordinated debt			5,175			2,155		55.68	%			11,293			860		10.18	%
Total interest-bearing liabilities			1,526,579			26,061		2.28	%			1,345,647			23,709		2.36	%
Noninterest-bearing deposits			975,278									972,525
Noninterest-bearing liabilities			24,580									22,776
Total liabilities			2,526,437									2,340,948
EQUITY			395,289									352,907
Total liabilities and equity		$	2,921,726								$	2,693,855
Taxable equivalent net interest income and margin (1)					$	104,810		5.08	%					$	100,198		5.29	%
GAAP net interest income					$	104,330		5.06	%					$	99,786		5.27	%
Cost of funds								1.39	%								1.37	%
(1) Interest income on investment securities, interest income on loans, net interest income and net interest margin are presented here on a taxable equivalent basis, using the statutory federal income tax rate of 21 percent, and are non-GAAP financial measures. Please see “Non-GAAP Financial Measures” below.
(2) Average balances on loans outstanding include nonaccrual loans, unamortized net deferred loan fees/costs and unaccreted purchase discount on acquired loans. The amortization of net loan origination fees and accretion of purchase discount on acquired loans are included in interest income on loans.

Noninterest Income 

Noninterest income for the third quarter of 2026 was $1.3 million, compared to $1.2 million for the second quarter of 2026. The quarter-over-quarter increase is largely attributed to a $153 thousand special dividend that was received on our holdings of FHLB of San Francisco stock during the third quarter.

Noninterest Expense

Noninterest expense for the third quarter of 2026 was $16.3 million, compared to $15.9 million for the second quarter of 2026. The quarter-over-quarter increase is largely attributed to increases in data and item processing costs, professional fees and various other miscellaneous expenses, partially offset by a decrease in salaries and employee benefits. The increase in data and item processing costs during the third quarter is primarily associated with the absence of one-time credits received from our core system processor that were utilized in the second quarter. The increase in professional fees can be attributed to expenses incurred related to Bancorp becoming an SEC registrant and a Nasdaq-listed company in the third quarter, as well as various other expenses associated with regular third-party credit reviews and other consulting fees. The decline in salaries and employee benefits during the quarter was primarily associated with the absence of expense associated with annual director stock grants that occurred in the second quarter, as well as increased compensation deferrals attributed to successful loan originations during the third quarter.

Investment Portfolio

Securities issued by U.S. government-sponsored agencies, U.S. Treasury bonds and Small Business Administration (“SBA”) securities accounted for 52%, 26% and 1%, respectively, of the investment portfolio as of September 30, 2026. These securities carry explicit or implicit credit guarantees from the U.S. government and thus present minimal credit or liquidity risk. Municipal bonds, corporate bonds and private-label collateralized mortgage obligations/asset-backed instruments represent 17%, 2% and 2% of the carrying value of the portfolio, respectively, as of September 30, 2026.

The investment portfolio totaled $377.9 million at September 30, 2026, compared to $388.1 million at June 30, 2026. The decrease in the investment portfolio from June 30, 2026, was primarily due to an increase in unrealized losses on AFS securities of $14.8 million, stemming from a rise in intermediate-term interest rates during the period, and maturities, paydowns and sales during the third quarter totaling $16.0 million, partially offset by purchases of U.S. Treasury securities, totaling $19.9 million. The investment portfolio had an effective duration of 3.8 years as of September 30, 2026, and June 30, 2026.

Net unrealized losses on AFS securities were $23.8 million, or $16.8 million after-tax, at September 30, 2026, compared to $9.0 million, or $6.3 million after-tax, at June 30, 2026.

Loans and Asset Quality

Total loans, net of unaccreted purchase discount and deferred fees and costs, increased $65.6 million, or 2.9%, from June 30, 2026. Loan growth during the third quarter of 2026 was largely attributed to increases in revolving commercial lines, which grew by $66.4 million during the quarter. This increase was primarily attributed to agriculture-related lending by the Bank’s San Luis Obispo County team. New loan commitments originated during the third quarter were $199.1 million, driven by $86.8 million in new commercial and industrial (“C&I”) commitments and $57.9 million in new commercial real estate (“CRE”) loan commitments.

Nonaccrual loans of $11.9 million accounted for 0.51% of total loans at September 30, 2026, compared to $11.4 million, or 0.50%, of total loans at June 30, 2026. At September 30, 2026, nonaccrual loans included a $5.8 million hotel relationship, consisting of two loans, of which one has an SBA guarantee of approximately $3.7 million. Other nonaccrual loans at September 30, 2026, consisted primarily of SBA-related credits totaling $4.7 million that contained SBA guarantees of approximately $4.0 million, and two CRE loans totaling approximately $1.4 million. At September 30, 2026, government guarantees of $7.8 million reduced net credit exposure on nonaccrual loans to approximately $4.1 million.

Accruing loans past due 30-89 days totaled $2.3 million at September 30, 2026, an increase from $1.2 million at June 30, 2026. The balance of accruing loans past due 30-89 days primarily reflects a $1.9 million substandard CRE loan that is secured by a mixed-use property. There were no loans more than 90 days past due still accruing as of September 30, 2026, or June 30, 2026.

The ACL on loans was $36.6 million at September 30, 2026, or 1.57%, of total loans, compared to $35.1 million at June 30, 2026, or 1.55%, of total loans. The increase in the ACL during the third quarter is attributed to several factors including organic loan growth and changes in portfolio mix which increased the ACL by approximately $1.5 million, and a $1.2 million increase in the ACL for certain individually evaluated loans. These increases were partially offset by lower pooled reserve rates reflecting improvements in the economic forecast as well as improvements in certain qualitative factors used in the ACL model. The provision for credit losses on loans was $275 thousand for the third quarter of 2026, compared to $1.4 million in the second quarter of 2026. The quarter-over-quarter decrease in the provision is largely attributed to the factors just discussed in addition to the full recovery, upon payoff, of a previously substantially charged-off loan in the amount of $1.2 million that occurred in the third quarter.

The Bank recorded net recoveries for the third quarter of 2026 of $1.2 million. Net recoveries for the quarter were largely attributed to the full recovery previously discussed.

The ACL for unfunded commitments, recorded in other liabilities, was $2.6 million, or 0.38% of unfunded credit commitments at September 30, 2026, compared to $2.9 million, or 0.42%, at June 30, 2026. The decrease in the ACL for unfunded commitments reflected, in part, higher utilization of commercial lines, which reduced unfunded commitments, and lower reserve rates consistent with improvements in the qualitative factors used to determine the ACL for funded loans. Total unfunded commitments decreased by approximately $6.3 million during the third quarter to $675.0 million as of September 30, 2026.

The following table summarizes the composition of the Bank’s loan portfolio as of the dates indicated:

	As of												Change % vs.
	September 30,				June 30,				September 30,				June 30,			September 30,
	2026				2026				2025				2026			2025
	(Dollars in thousands)
SBA and business and industry loans	$	162,956			$	168,665			$	177,493			(3.4	)%		(8.2	)%
Commercial term loans		129,720				128,542				123,755			0.9	%		4.8	%
Revolving commercial lines		282,692				216,275				168,864			30.7	%		67.4	%
Asset-based lines of credit		54,343				49,926				45,117			8.8	%		20.4	%
Construction loans		254,825				262,513				246,774			(2.9	)%		3.3	%
Commercial real estate loans		1,420,402				1,413,772				1,345,230			0.5	%		5.6	%
Home equity lines of credit		37,246				36,956				37,239			0.8	%		—	%
Consumer and other loans		6,263				8,198				3,596			(23.6	)%		74.2	%
Deferred loan expenses, net of fees		2,610				2,281				2,160			14.4	%		20.8	%
Total loans, net of deferred fees and costs		2,351,057				2,287,128				2,150,228			2.8	%		9.3	%
Purchase discount on acquired loans		(14,059	)			(15,722	)			(23,050	)		(10.6	)%		(39.0	)%
Total loans, net of unaccreted purchase discount	$	2,336,998			$	2,271,406			$	2,127,178			2.9	%		9.9	%

The following table summarizes delinquent and nonperforming loans, net of deferred fees and costs, and purchase discounts as of the dates indicated:

	As of or for the Periods Ended
	September 30,				June 30,			September 30,
	2026				2026			2025
	(Dollars in thousands)
Loans past due 30-89 days	$	2,318			$	1,244		$	8,418
Loans past due 30-89 days, net of government guaranteed amounts	$	2,318			$	1,244		$	4,693
Delinquent loans (past due 90+ days still accruing)	$	—			$	—		$	—
Nonaccrual loans		11,881				11,442			14,355
Other real estate owned		6,874				6,874			—
Nonperforming assets	$	18,755			$	18,316		$	14,355
Nonperforming assets, net of government guaranteed amounts	$	11,007			$	10,002		$	12,495
Net loan (recoveries) charge-offs QTD	$	(1,214	)		$	944		$	—
Net loan charge-offs YTD	$	3,098			$	4,312		$	27

Deposits

Deposits totaled $2.6 billion at September 30, 2026, an increase of $32.5 million, or 1.3%, compared to June 30, 2026. The increase in deposits during the third quarter of 2026 was driven by the establishment of a few large new-client relationships that brought in money market deposits during the quarter, as well as seasonal deposit inflows. Noninterest-bearing deposits to total deposits was 39.0% and 39.7% at September 30, 2026, and June 30, 2026, respectively.

The 10 largest deposit relationships, excluding fully collateralized government agency deposits, represent approximately 15.0% of total deposits as of September 30, 2026. The Bank generally aggregates related depositors with entities and individuals that have the same deposit account signers as one deposit relationship.

The following table summarizes the composition of the Bank’s deposits as of the dates indicated:

	As of									Change % vs.
	September 30,			June 30,			September 30,			June 30,			September 30,
	2026			2026			2025			2026			2025
	(Dollars in thousands)
Noninterest-bearing demand	$	996,593		$	1,002,579		$	1,058,787		(0.6	)%		(5.9	)%
Interest-bearing demand		235,923			230,837			235,025		2.2	%		0.4	%
Money markets		1,023,335			984,500			810,311		3.9	%		26.3	%
Savings		166,787			166,673			181,282		0.1	%		(8.0	)%
Time certificates of deposit		132,547			138,104			150,692		(4.0	)%		(12.0	)%
Total deposits	$	2,555,185		$	2,522,693		$	2,436,097		1.3	%		4.9	%
Deposits – personal	$	776,887		$	781,810		$	779,312		(0.6	)%		(0.3	)%
Deposits – business		1,778,298			1,740,883			1,656,785		2.1	%		7.3	%
Total deposits	$	2,555,185		$	2,522,693		$	2,436,097		1.3	%		4.9	%

Liquidity Position

The following table summarizes the Bank’s liquidity for each period reported:

	As of
	September 30,			June 30,			September 30,
	2026			2026			2025
	(Dollars in thousands)
Cash and cash equivalents	$	116,929		$	146,873		$	143,504
Interest-earning deposits in other financial institutions		100			100			249
Unencumbered AFS securities		232,614			235,993			326,183
Total on-balance-sheet liquidity		349,643			382,966			469,936
Line of credit from the FHLB of San Francisco – collateralized		736,073			723,750			662,537
Line of credit from the FRB of San Francisco – collateralized		445,177			412,909			382,095
Lines at correspondent banks – unsecured		100,000			100,000			100,000
Total external contingency liquidity capacity		1,281,250			1,236,659			1,144,632
Less: short-term borrowings		—			—			—
Net available liquidity sources	$	1,630,893		$	1,619,625		$	1,614,568

As of September 30, 2026, net liquidity of $1.63 billion exceeded uninsured and uncollateralized deposits of approximately $1.35 billion, with a coverage ratio of 120%.

Shareholders’ Equity

Total shareholders’ equity was $402.6 million at September 30, 2026, a $4.1 million, or 1.0%, increase compared to June 30, 2026. Tangible common equity, a non-GAAP measure, was $341.6 million at September 30, 2026, a $5.1 million, or 1.5%, increase compared to June 30, 2026. The quarter-over-quarter change in tangible common equity is largely attributed to net income of $16.7 million, activity related to stock-based compensation and the amortization of core deposit intangibles, together totaling $1.5 million, partially offset by an increase in accumulated other comprehensive loss of $10.5 million due to higher unrealized losses on AFS investment securities during the quarter, and dividends declared of $2.6 million. Tangible book value per share, a non-GAAP measure, was $32.46 at September 30, 2026, compared to $32.01 at June 30, 2026. Please see “Non-GAAP Financial Measures” below.

ABOUT WEST COAST COMMUNITY BANCORP AND WEST COAST COMMUNITY BANK

West Coast Community Bancorp is the bank holding company for West Coast Community Bank. Founded in 2004, the Bank is a top-rated, locally operated and full-service community bank headquartered in Santa Cruz, Calif. with branches in Aptos, Capitola, King City, Monterey, Salinas, San Jose, San Luis Obispo, San Mateo, Santa Cruz, Scotts Valley and Watsonville. West Coast Community Bank is distinguished from “big banks” by its relationship-based service, problem-solving focus and direct access to decision makers. The Bank also is an SBA Preferred Lending Partner. As a full-service bank, West Coast Community Bank offers competitive deposit and lending solutions for businesses and individuals; including business loans, lines of credit, commercial real estate financing, construction lending, asset-based lending, agricultural loans, SBA and USDA government guaranteed loans, credit cards, merchant services, remote deposit capture, mobile and online banking, bill payment and treasury management. Additional information regarding the Company’s recent industry recognition, community engagement, and financial performance is included in the accompanying investor presentation and at investors.wccb.com.

Forward-Looking Statements

This release may contain statements that we believe are, or may be considered to be, “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based on our current beliefs, expectations or assumptions regarding the future of the business, future plans and strategies, operational results and other future conditions of the Company. All statements other than statements of historical fact included in this release may constitute forward-looking statements, including statements regarding the prospects of our industry or our prospects, plans, expected operating results, financial position or business strategy. In addition, forward-looking statements generally can be identified by the use of forward-looking words such as “plan,” “expect,” “look forward to,” “budget,” “scheduled,” “estimate,” “forecast,” “continue,” “intend,” “potential,” “anticipate,” “believe,” “should,” “may,” “could,” “would,” “might,” “seek,” “will,” “be taken,” “occur,” “be achieved” or the negative of these terms or variations of them or similar terms. Although we believe that the expectations reflected in these forward-looking statements are reasonable, we cannot assure you that these expectations will prove to be correct. These forward-looking statements are subject to certain known and unknown risks and uncertainties that could cause actual results to differ materially from those reflected in these forward-looking statements. Such risks and uncertainties may include but are not necessarily limited to fluctuations in interest rates (including but not limited to changes in depositor behavior and/or impacts on our core deposit intangible in relation thereto), inflation, government regulations and general economic conditions and competition within the business areas in which the Company and the Company’s clients are conducting their operations, including the impact of proposed or imposed tariffs or other trade restrictions, labor or supply chain issues, health of the real estate market in California, the Company’s ability to effectively execute its business plans, other factors beyond the Company’s control and those risks and uncertainties described in our filings with the Securities and Exchange Commission (“SEC”), which are available on the Investor Relations page of our website at investors.wccb.com and on the SEC’s website at www.sec.gov. Therefore, we caution you not to place undue reliance on any forward-looking statements contained herein, which reflect management’s opinions only as of the date hereof. Except as required by law, we undertake no obligation to revise or publicly release the results of any revision to any forward-looking statements.

Concurrent with this earnings release, the Company issued presentation slides providing supplemental information intended to be reviewed together with this release. Slides may be viewed online at: investors.wccb.com.

MEDIA CONTACTS
Krista Snelling, Chairman and Chief Executive Officer
Cecilia Situ, Executive Vice President and Chief Financial Officer
investorrelations@wccb.com

Consolidated Balance Sheets (Unaudited)

	As of
	September 30,				June 30,				September 30,
	2026				2026				2025
	(Dollars in thousands)
ASSETS
Cash and cash equivalents	$	116,929			$	146,873			$	143,504
Interest-earning deposits in other financial institutions		100				100				249
Investment securities available for sale, net of allowance of credit losses of $0		371,517				381,745				428,007
Investment securities held to maturity, net of allowance for credit losses of $0		6,365				6,383				6,570
Loans held for investment		2,336,998				2,271,406				2,127,178
Less: Allowance for credit losses on loans		(36,608	)			(35,119	)			(37,091	)
Loans, net of allowance		2,300,390				2,236,287				2,090,087
Non-marketable equity investments, at cost		15,370				15,370				15,355
Premises and equipment, net		10,677				10,814				10,206
Goodwill		40,054				40,054				40,054
Core deposit intangible asset, net		20,899				21,885				24,849
Bank-owned life insurance		30,105				29,897				28,097
Accrued interest receivable and other assets		71,178				55,797				51,193
Total assets	$	2,983,584			$	2,945,205			$	2,838,171
LIABILITIES
Deposits
Noninterest-bearing	$	996,593			$	1,002,579			$	1,058,787
Interest-bearing		1,558,592				1,520,114				1,377,310
Total deposits		2,555,185				2,522,693				2,436,097
Subordinated debentures		—				—				11,092
Accrued interest payable and other liabilities		25,809				24,024				22,486
Total liabilities		2,580,994				2,546,717				2,469,675
SHAREHOLDERS’ EQUITY
Preferred stock, no par value; 10,000,000 shares authorized; no shares issued or outstanding		—				—				—
Common stock, no par value; 30,000,000 shares authorized; 10,524,552, 10,513,743, and 10,537,167 outstanding as of September 30, 2026, June 30, 2026, and September 30, 2025, respectively		200,013				199,528				203,493
Retained earnings		218,780				204,667				170,992
Accumulated other comprehensive loss, net of taxes		(16,203	)			(5,707	)			(5,989	)
Total shareholders’ equity		402,590				398,488				368,496
Total liabilities and shareholders’ equity	$	2,983,584			$	2,945,205			$	2,838,171

Consolidated Statements of Income (Unaudited)

	For the Three Months Ended												For the Nine Months Ended
	September 30,				June 30,				September 30,				September 30,				September 30,
	2026				2026				2025				2026				2025
	(Dollars in thousands, except per share data)
Interest Income
Loans, including fees	$	40,568			$	38,562			$	38,334			$	116,235			$	112,288
Interest-earning deposits in other financial institutions		1,386				893				1,284				3,646				1,734
Taxable securities		3,252				2,975				2,693				9,063				7,725
Tax-exempt securities		456				463				570				1,447				1,748
Total interest income		45,662				42,893				42,881				130,391				123,495
Interest Expense
Deposits		8,552				7,764				8,018				23,906				22,437
Subordinated debentures		—				1,991				229				2,155				860
FHLB advances and other borrowings		—				—				—				—				412
Total interest expense		8,552				9,755				8,247				26,061				23,709
Net interest income before provision for credit losses		37,110				33,138				34,634				104,330				99,786
Provision for credit losses on loans		275				1,386				3,540				1,533				5,442
(Reversal of) provision for credit losses on unfunded loan commitments		(268	)			128				(50	)			(371	)			50
Net interest income after provision for credit losses		37,103				31,624				31,144				103,168				94,294
Noninterest Income
Service charges on deposits		282				246				177				778				515
Loan servicing fees		81				101				126				289				394
ATM fee income		269				268				280				794				835
Earnings on bank-owned life insurance		208				205				185				613				547
Dividends on non-marketable equity securities		309				174				281				1,139				856
Loss on sale of securities		(34	)			(65	)			(2	)			(2	)			(281	)
Gain on sale of loans		—				—				—				912				—
Loss on sale of other assets		(29	)			—				—				(26	)			—
Other		217				247				238				692				817
Total noninterest income		1,303				1,176				1,285				5,189				3,683
Noninterest Expense
Salaries and employee benefits		8,660				9,114				8,300				26,312				25,538
Occupancy		910				944				797				2,711				2,517
Furniture and equipment		1,063				1,108				888				3,192				2,705
Marketing, business development and shareholder-related expense		431				352				519				1,066				1,440
Data and item processing		816				438				698				1,736				2,069
Regulatory assessments, including federal deposit insurance		394				403				369				1,188				1,160
Amortization of core deposit intangibles		986				987				1,068				2,959				3,202
Professional fees		779				439				629				2,475				1,358
Acquisition-related expense		—				—				150				—				497
Other		2,215				2,083				2,073				6,519				5,950
Total noninterest expense		16,254				15,868				15,491				48,158				46,436
Income before income taxes		22,152				16,932				16,938				60,199				51,541
Income tax expense		5,412				4,771				4,877				16,311				14,884
Net income	$	16,740			$	12,161			$	12,061			$	43,888			$	36,657
Weighted Average Common Shares Outstanding
Basic		10,380,906				10,369,791				10,489,496				10,369,257				10,505,896
Diluted		10,542,098				10,507,662				10,601,694				10,513,013				10,617,773
Earnings per share
Basic	$	1.61			$	1.17			$	1.15			$	4.23			$	3.49
Diluted	$	1.59			$	1.16			$	1.14			$	4.17			$	3.45

Non-GAAP Financial Measures

In addition to presenting the Company’s results of operations in accordance with generally accepted accounting principles (“GAAP”) in the United States of America, certain financial measures discussed herein are non-GAAP financial measures, examples of which include taxable equivalent net interest income, efficiency ratio, tangible common equity ratio and return on average tangible equity. Generally, a non-GAAP measure is a numerical measure of a company’s financial performance, financial position or cash flows that exclude (or include) amounts that are included in (or excluded from) the most directly comparable measure calculated and presented in accordance with GAAP. We believe that the non-GAAP financial measures used herein provide helpful additional information about our operating results, performance trends and financial condition. Non-GAAP measures should not be considered a substitute for GAAP results and may not be comparable to similar measures used by other banking companies, among other limitations. Other companies may use the same or similar names for non-GAAP measures but may calculate them differently. As a result, caution should be used when comparing the Company’s non-GAAP measures with those of other companies.

Investors are encouraged to review the reconciliation of non-GAAP financial measures used herein to their most directly comparable GAAP financial measures, which are presented in the tables below.

The following tables present non-GAAP financial measures management believes provide useful information for understanding the operating results of our core business and a better comparison of financial performance. Such measures include taxable equivalent adjustments, adjustments related to the sub debt redemption in the second quarter of 2026, adjustments related to the income tax benefit from the investment in renewable energy tax credits in the third quarter of 2026, tangible common equity and the associated financial measures.

Non-GAAP Financial Measures

	For the Three Months Ended										For the Nine Months Ended
	September 30,			June 30,				September 30,			September 30,
	2026			2026				2025			2026				2025
	(Dollars in thousands, except per share data)
Total Interest Income (taxable equivalent):
Total interest income on loans	$	40,568		$	38,562			$	38,334		$	116,235			$	112,288
Add: taxable equivalent adjustment for loans		91			69				22			188				66
Total interest income on loans (taxable equivalent)	$	40,659		$	38,631			$	38,356		$	116,423			$	112,354
Total interest income on investment securities	$	3,708		$	3,438			$	3,263		$	10,510			$	9,473
Add: taxable equivalent adjustment for investment securities		89			92				111			292				346
Total interest income on investment securities (taxable equivalent)	$	3,797		$	3,530			$	3,374		$	10,802			$	9,819
Total interest income on interest-earning cash		1,386			893				1,284			3,646				1,734
Total interest income (taxable equivalent)	$	45,842		$	43,054			$	43,014		$	130,871			$	123,907
Adjusted Interest Expense:
Interest expense	$	8,552		$	9,755			$	8,247		$	26,061			$	23,709
Less: accelerated accretion on sub debt redemption		—			(1,824	)			—			(1,824	)			(160	)
Adjusted interest expense	$	8,552		$	7,931			$	8,247		$	24,237			$	23,549
Net Interest Income (taxable equivalent):
Net interest income	$	37,110		$	33,138			$	34,634		$	104,330			$	99,786
Add: total taxable equivalent adjustment		180			161				133			480				412
Net interest income (taxable equivalent)	$	37,290		$	33,299			$	34,767		$	104,810			$	100,198
Adjusted Net Interest Income:
Net interest income	$	37,110		$	33,138			$	34,634		$	104,330			$	99,786
Add: accelerated accretion on sub debt redemption		—			1,824				—			1,824				160
Adjusted net interest income	$	37,110		$	34,962			$	34,634		$	106,154			$	99,946
Adjusted Net Interest Income (taxable equivalent):
Net interest income	$	37,110		$	33,138			$	34,634		$	104,330			$	99,786
Add: taxable equivalent adjustment		180			161				133			480				412
Add: accelerated accretion on sub debt redemption		—			1,824				—			1,824				160
Adjusted net interest income (taxable equivalent)	$	37,290		$	35,123			$	34,767		$	106,634			$	100,358
Average loans	$	2,300,973		$	2,233,133			$	2,109,593		$	2,237,480			$	2,096,800
Average investment securities	$	394,507		$	382,863			$	385,235		$	388,635			$	381,978
Average interest-earning assets	$	2,844,497		$	2,714,207			$	2,610,884		$	2,758,966			$	2,531,698
Average deposits and borrowed funds	$	2,580,596		$	2,459,749			$	2,388,059		$	2,501,857			$	2,318,172

Non-GAAP Financial Measures (Continued)	For the Three Months Ended												For the Nine Months Ended
	September 30,				June 30,				September 30,				September 30,
	2026				2026				2025				2026				2025
	(Dollars in thousands, except per share data)
Yield on loans		6.99	%			6.93	%			7.21	%			6.95	%			7.16	%
Yield on loans (taxable equivalent)		7.01	%			6.94	%			7.21	%			6.96	%			7.16	%
Yield on investments		3.73	%			3.60	%			3.36	%			3.62	%			3.32	%
Yield on investments (taxable equivalent)		3.82	%			3.70	%			3.47	%			3.72	%			3.44	%
Yield on interest-earning assets		6.37	%			6.34	%			6.52	%			6.32	%			6.52	%
Yield on interest-earning assets (taxable equivalent)		6.39	%			6.36	%			6.54	%			6.34	%			6.54	%
Net interest margin		5.18	%			4.90	%			5.26	%			5.06	%			5.27	%
Net interest margin (taxable equivalent)		5.20	%			4.92	%			5.28	%			5.08	%			5.29	%
Adjusted Net interest margin (taxable equivalent)		5.20	%			5.19	%			5.28	%			5.17	%			5.30	%
Cost of funds		1.31	%			1.59	%			1.37	%			1.39	%			1.37	%
Adjusted cost of funds		1.31	%			1.29	%			1.37	%			1.30	%			1.36	%
Adjusted Efficiency Ratio:
Noninterest expense	$	16,254			$	15,868			$	15,491			$	48,158			$	46,436
Noninterest income	$	1,303			$	1,176			$	1,285			$	5,189			$	3,683
Net interest income	$	37,110			$	33,138			$	34,634			$	104,330			$	99,786
Add: accelerated accretion on sub debt redemption		—				1,824				—				1,824				160
Adjusted net interest income	$	37,110			$	34,962			$	34,634			$	106,154			$	99,946
Efficiency ratio		42.31	%			46.24	%			43.13	%			43.97	%			44.88	%
Adjusted efficiency ratio		42.31	%			43.91	%			43.13	%			43.25	%			44.81	%
Adjusted Net Income and EPS:
Net income	$	16,740			$	12,161			$	12,061			$	43,888			$	36,657
Add: accelerated accretion on sub debt redemption		—				1,824				—				1,824				160
Less: tax adjustment for accelerated accretion on sub debt redemption (1)		—				(539	)			—				(539	)			(47	)
Less: renewable energy investment tax credit benefit		(920	)			—				—				(920	)			—
Adjusted net income	$	15,820			$	13,446			$	12,061			$	44,253			$	36,770
Basic weighted average common shares outstanding		10,380,906				10,369,791				10,489,496				10,369,257				10,505,896
Diluted weighted average common shares outstanding		10,542,098				10,507,662				10,601,694				10,513,013				10,617,773
Basic EPS	$	1.61			$	1.17			$	1.15			$	4.23			$	3.49
Diluted EPS	$	1.59			$	1.16			$	1.14			$	4.17			$	3.45
Adjusted basic EPS	$	1.52			$	1.29			$	1.15			$	4.27			$	3.50
Adjusted diluted EPS	$	1.50			$	1.28			$	1.14			$	4.21			$	3.46

Non-GAAP Financial Measures (Continued)	For the Three Months Ended												For the Nine Months Ended
	September 30,				June 30,				September 30,				September 30,
	2026				2026				2025				2026				2025
	(Dollars in thousands, except per share data)
Return on Average Tangible Equity:
Net income	$	16,740			$	12,161			$	12,061			$	43,888			$	36,657
Add: amortization of intangible assets		986				987				1,068				2,959				3,202
Less: tax adjustment (1)		(291	)			(292	)			(316	)			(875	)			(947	)
Net income, adjusted for amortization of intangibles	$	17,435			$	12,856			$	12,813			$	45,972			$	38,912
Net income	$	16,740			$	12,161			$	12,061			$	43,888			$	36,657
Add: accelerated accretion on sub debt redemption		—				1,824				—				1,824				160
Less: tax adjustment for accelerated accretion on sub debt redemption (1)		—				(539	)			—				(539	)			(47	)
Less: renewable energy investment tax credit benefit		(920	)			—				—				(920	)			—
Net income, adjusted for accelerated accretion on sub debt redemption and renewable energy tax credit investment benefit	$	15,820			$	13,446			$	12,061			$	44,253			$	36,770
Net income, adjusted for amortization of intangibles	$	17,435			$	12,856			$	12,813			$	45,972			$	38,912
Add: accelerated accretion on sub debt redemption		—				1,824				—				1,824				160
Less: tax adjustment for accelerated accretion on sub debt redemption(1)		—				(539	)			—				(539	)			(47	)
Less: renewable energy investment tax credit benefit		(920	)			—				—				(920	)			—
Net income, adjusted for amortization of intangibles, accelerated accretion on sub debt redemption, and renewable energy investment tax credit benefit	$	16,515			$	14,141			$	12,813			$	46,337			$	39,025
Average equity	$	404,098			$	395,954			$	363,685			$	395,289			$	352,907
Less: average intangible assets		(61,585	)			(62,579	)			(65,592	)			(62,568	)			(66,651	)
Average tangible equity	$	342,513			$	333,375			$	298,093			$	332,721			$	286,256
Return on average equity		16.44	%			12.32	%			13.16	%			14.84	%			13.89	%
Return on average equity, adjusted for accelerated accretion on sub debt redemption and renewable energy investment tax credit benefit		15.53	%			13.62	%			13.16	%			14.97	%			13.93	%
Return on average tangible equity		20.20	%			15.47	%			17.05	%			18.47	%			18.17	%
Return on average tangible equity, adjusted for accelerated accretion on sub debt redemption and renewable energy investment tax credit benefit		19.13	%			17.01	%			17.05	%			18.62	%			18.23	%
Adjusted Return on Average Assets:
Net income	$	16,740			$	12,161			$	12,061			$	43,888			$	36,657
Add: accelerated accretion on sub debt redemption		—				1,824				—				1,824				160
Less: tax adjustment for accelerated accretion on sub debt redemption (1)		—				(539	)			—				(539	)			(47	)
Less: renewable energy investment tax credit benefit		(920	)			—				—				(920	)			—
Net income, adjusted for accelerated accretion on sub debt redemption and renewable energy investment tax credit benefit	$	15,820			$	13,446			$	12,061			$	44,253			$	36,770
Average assets	$	3,011,804			$	2,879,579			$	2,772,657			$	2,921,726			$	2,693,855
Return on average assets		2.21	%			1.69	%			1.73	%			2.01	%			1.82	%
Adjusted return on average assets		2.08	%			1.87	%			1.73	%			2.03	%			1.82	%
(1) Adjusted by combined statutory federal income tax rate of 21 percent and statutory state income tax rate of 10.84 percent.

Non-GAAP Financial Measures (Continued)	As of or for the Three Months Ended
	September 30,				June 30,				September 30,
	2026				2026				2025
	(Dollars in thousands, except per share data)
Tangible Common Equity:
Total shareholders’ equity	$	402,590			$	398,488			$	368,496
Less: goodwill and other intangibles		(60,953	)			(61,939	)			(64,903	)
Tangible common equity	$	341,637			$	336,549			$	303,593
Add: accelerated accretion on sub debt redemption		—				1,824				—
Less: tax adjustment (1)		—				(539	)			—
Adjusted tangible common equity (2)	$	341,637			$	337,834			$	303,593
Tangible book value per share	$	32.46			$	32.01			$	28.81
Adjusted tangible book value per share (2)	$	32.46			$	32.13			$	28.81
Tangible Assets:
Total assets	$	2,983,584			$	2,945,205			$	2,838,171
Less: goodwill and other intangibles		(60,953	)			(61,939	)			(64,903	)
Tangible assets	$	2,922,631			$	2,883,266			$	2,773,268
Total shareholders’ equity to total assets		13.49	%			13.53	%			12.98	%
Tangible common equity ratio		11.69	%			11.67	%			10.95	%
(1) Adjusted by combined statutory federal income tax rate of 21 percent and statutory state income tax rate of 10.84 percent.
(2) Adjusted tangible common equity and adjusted tangible book value per share are presented to illustrate the effect of excluding the after-tax accelerated accretion associated with the completed subordinated-debt redemption. These measures do not represent Bancorp’s actual period-end equity or book value.

• The AvePoint Trust Platform makes data AI-ready, governs every agent across its lifecycle, and keeps businesses resilient – independent of any single cloud or AI provider
• New AI Governance and Security capabilities give one place to discover AI agents, models, tools, and MCP servers, apply policies, and produce audit-ready evidence
• New AI Cost Optimization democratizes AI budgeting and shows where AI spend pays off
• New visibility and control over Anthropic Claude, Windows, and server-hosted agents

JERSEY CITY, N.J., Oct. 27, 2026 (GLOBE NEWSWIRE) — AvePoint (Nasdaq: AVPT; SGX: AVP), the AI Trust Company, today announced the AvePoint Trust Platform, which empowers organizations to govern, secure, and optimize AI. The platform makes data AI-ready, governs every agent across its lifecycle, and keeps the business resilient when AI gets it wrong – independent of any single cloud, model, or AI provider. The launch includes new AI Governance, Security, and Cost Optimization capabilities, broadening observability to Anthropic Claude, Windows, and server-hosted agents, as well as the tools, MCP servers, and the models agents are accessing.

AI Will Find Everything Organizations Forgot They Had

For decades, most enterprise data has been protected by the fact that nobody was searching for it. AI has ended that. A copilot or agent reads everything it is permitted to read and can act on it thousands of times an hour, without breaking a single rule. According to AvePoint’s State of AI 2026 Report, 88.4% of organizations experienced at least one AI agent-related security incident in the past 12 months, including those confident they could prevent unauthorized AI access to data.

What AI Trust Means  

The solution to this challenge is what AvePoint calls AI Trust: the ability to prove that AI runs on governed data, with least-privilege access, under policies enforced at the moment of action, with audit evidence and full recoverability. If any one of these cannot be proven, the AI is not trusted – it is merely running. AI Trust works alongside the security and identity tools enterprises already run to stop intruders. AI Trust governs what trusted people and agents can reach and do and enables rapid recovery when something goes wrong.

“Every organization now has access to the same AI capabilities. What truly sets them apart is how far that AI can safely reach, what permissions it actually has, and whether there’s a way to reverse course when it makes a wrong call. That’s the real test of AI Trust, and it’s the foundation for this new agent-driven era,” said Dr. Tianyi Jiang (TJ), CEO and Co-Founder, AvePoint. “For 25 years, we’ve been understanding how enterprise data behaves in the real world, not just in theory. The AvePoint Trust Platform brings that understanding to every agent, model, and partner that touches that data. It operates independently across vendors and technologies, because in today’s world, risk doesn’t stop at the vendor’s edge.”

Introducing the AvePoint Trust Platform

The AvePoint Trust Platform takes enterprises from unmanaged AI to measurable trust across every agent, application, model and AI vendor, and is built on four disciplines: Observe, Protect, Govern, and Optimize.

• Observe: See what AI can reach. The platform discovers sanctioned and shadow agents, including those built by citizen developers, and shows which content is overshared, stale or unlabeled before an agent finds it.
• Protect: Keep the business recoverable. Backup and recovery for Microsoft 365, Power Platform, SaaS applications such as ServiceNow, and cloud infrastructure across Azure, AWS, and Google Cloud extends to agents themselves. A Copilot Studio agent, including its configuration, logic, prompts, topics, and flows, can be restored to a known-good state.
• Govern: Govern every agent across its lifecycle. Each agent is assigned an owner, policy, and data sensitivity context, with business-owner attestation and recertification delivered in Slack, Teams and email, from discovery to retirement.
• Optimize: Turn data and AI consumption into value. The platform eliminates unnecessary content, improves prompt effectiveness and brings visibility to token consumption and budgeting so organizations can focus AI resources on the information and initiatives that matter most.

“As organizations scale AI, they need the right foundation to innovate with trust and without introducing new risks,” said Randy Simmons, Sr. Managing Director, EY AI Workplace Practice. “AvePoint addresses a critical need we are seeing in the large enterprise market, giving organizations more visibility, control and protection as their AI environments grow. We believe that together, EY and AvePoint can help our clients rapidly scale AI with greater trust and confidence.”

The AvePoint Trust Platform can detect and prevent risk before it happens, roll back what an agent changed, and issue signed charters that define what each agent may do. The four disciplines are built on AvePoint’s Governance Graph, which joins global regulatory intelligence, such as the EU AI Act, ISO 42001 and the NIST AI Risk Management Framework, with each organization’s business context: its owners, policies, information barriers and the purpose of every workspace and agent. The Graph is designed to learn how an organization makes decisions, from owner attestations to the conversations where decisions happen, so each ruling applies to every operation that follows.

New AI Governance and Security Capabilities Give One View of Every AI Asset

New AI Governance and Security capabilities give security, IT, and compliance teams a single system of record for every AI asset in the enterprise, from discovery through policy enforcement, to audit-ready evidence. These include:

• AI estate visibility and governance: AI Inventory, AI Dependency Graph and Shadow AI Detection capabilities discover agents, models, tools, MCP servers and other AI assets, map the relationships among them and to global regulatory frameworks, and identify unsanctioned activity.
• Agent monitoring: Enhanced policies identify ownerless agents, monitor agent access and sensitive content, and apply governance directly to the agents acting on behalf of employees.
• Continuous data security and classification: Expanded DSPM and Kinetic Classification capabilities give organizations more precision in defining risk, identifying and tagging AI-generated content, and connecting classification and risk insights to automated remediation.

New AI Cost Optimization Shows Where AI Spend Pays Off

AI Cost Optimization brings AI spend, usage, and adoption data together so IT and Finance teams can more precisely evaluate the return on their AI investments, particularly as Gartner projects AI spend will grow 49.5% in 2026. New capabilities include:

• AI budget requests: Replaces budget requests managed through email and spreadsheets with a structured process that gives employees a way to request additional AI budget, and gives managers usage and ROI context to approve, adjust or deny those requests.
• AI adoption coaching and nudges: Identifies where utilization is low and delivers targeted guidance that helps employees use licensed AI tools more effectively.

AvePoint Adds Anthropic Claude and MCP Server Discovery

The AvePoint Trust Platform also now supports Anthropic models and MCP servers, and discovers and inventories agents built with Anthropic’s Claude and connected MCP servers, alongside agents in Microsoft Copilot Studio and Foundry, Google Vertex AI and Salesforce Agentforce.

Get early access to the AvePoint Trust Platform by signing up for the private preview or see a live demo at Microsoft Ignite, Nov. 17-20, Booth 5535.

About AvePoint

AvePoint is the AI Trust Company. AvePoint helps more than 28,000 organizations and 6,000 channel partners govern, secure, and scale AI with trust: making data AI-ready, governing every agent across its lifecycle, and keeping the business resilient across every cloud they run on. To learn more, visit www.avepoint.com.

Forward-Looking Statements
This press release contains certain forward-looking statements within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995 and other federal securities laws including statements regarding the future performance of and market opportunities for AvePoint. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: changes in the competitive and regulated industries in which AvePoint operates, variations in operating performance across competitors, changes in laws and regulations affecting AvePoint’s business and changes in AvePoint’s ability to implement business plans, forecasts, and ability to identify and realize additional opportunities, and the risk of downturns in the market and the technology industry. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of AvePoint’s most recent Annual Report on Form 10-K. Copies of this and other documents filed by AvePoint from time to time are available on the SEC’s website, www.sec.gov. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and AvePoint does not assume any obligation and does not intend to update or revise these forward-looking statements after the date of this release, whether as a result of new information, future events, or otherwise, except as required by law. AvePoint does not give any assurance that it will achieve its expectations. Unless the context otherwise indicates, references in this press release to the terms “AvePoint,” “the Company,” “we,” “our” and “us” refer to AvePoint, Inc. and its subsidiaries.

Disclosure Information

AvePoint uses the https://www.avepoint.com/ir website as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Investor Contact
AvePoint
Jamie Arestia
ir@avepoint.com  
(551) 220-5654

Media Contact
AvePoint
Nicole Caci
pr@avepoint.com  
(201) 201-8143

The brand’s newest product extension offers families kid-friendly coconut beverages designed for little ones and their on-the-go moments

NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) — Vita Coco® (NASDAQ: COCO), America’s leading coconut water brand, is bringing the delicious, hydrating power of coconut water to a 200mL pack with a paper straw, designed just for kids, available at select Walmart stores.

Vita Coco has long been a part of families’ routines, with parents and kids alike enjoying its great taste, electrolytes, and lower sugar content. With Vita Coco Kids, the brand is building on that connection by offering a convenient, kid-sized format that’s easy to pack for school, activities, and on-the-go moments.

Vita Coco Kids will be available in two varieties:

• Vita Coco Kids Original Coconut Water: Packed with electrolytes and nutrients, this is the coconut water parents already know and trust, now available in a kid-sized 200mL pack with a paper straw.
• Vita Coco Kids Strawberry Coconutmilk Beverage: A dairy-free strawberry-flavored coconutmilk beverage with 0g of added sugar, offering kids a flavor-forward way into Vita Coco in a kid-sized 200mL pack with a paper straw.

Together, the Vita Coco Kids options give parents flexibility based on what their little one is reaching for that day: Original Coconut Water packed with electrolytes or the flavorful Strawberry Coconutmilk Beverage.

“Vita Coco Kids is about meeting the next generation of coconut water drinkers where they are,” said Jane Prior, Chief Marketing Officer at The Vita Coco Company. “Families are already bringing Vita Coco into their kids’ routines, so we saw an opportunity to create something specifically for them: fun, convenient options that parents can feel good about providing and that kids will enjoy sipping.”

For additional information about Vita Coco, visit vitacoco.com and follow the brand on Instagram, TikTok, X and Facebook.

About The Vita Coco Company®
The Vita Coco Company is a family of brands on a mission to reimagine what’s possible when brands deliver healthy, nutritious and great tasting products that are better for consumers and better for the world. This includes its flagship coconut water brand Vita Coco, and Copra, a super-premium brand that specializes in Thai Nam Hom coconut water. The Company was co-founded in 2004 by Michael Kirban and Ira Liran and is a public benefit corporation and Certified B Corporation. Vita Coco, the principal brand within the Company’s portfolio, is the leading coconut water brand in the U.S. With electrolytes and nutrients, coconut water has become a top beverage choice among consumers after a workout, in smoothies, as a cocktail mixer, after a night out, and more.

Press Contact
vitacoco@autumncommunications.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/90dd9be8-953e-4362-97d5-53b6b9ba13f7

SAN DIEGO, Oct. 27, 2026 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that financial advisor Matt Griggs, AAMS®, CRPC™, of Griggs Investment Group has joined LPL Financial’s broker-dealer and Registered Investment Advisor (RIA) platforms. Griggs reported serving approximately $160 million in advisory, brokerage and retirement plan assets* and joins LPL from Edward Jones.

Based in Eufaula, Alabama, Griggs serves individuals and families across generations, including clients in the agricultural community and government employees navigating workplace retirement plan distributions. His clients span a wide range of ages, and his practice includes multigenerational relationships that have carried over from parents to their children. He is supported by Client Service Associate Cheryl Pitts.

Griggs has built his practice by getting to know the person behind each account. He believes understanding a client’s story and relationship with money can provide important context for developing an approach that fits the individual. He typically meets with clients quarterly and emphasizes education, accessibility and straightforward conversations about their financial lives.

“Clients are never just an account number to me. There’s a person, a family and a story behind every relationship,” Griggs said. “I want to understand where clients come from, how they think about money and what they want their lives to look like. From there, my role is to make the financial side easier to understand. Ultimately, I want clients to be able to leave the stress about money at the door.”

Financial education is also an important part of Griggs’s approach. In his community, he volunteers his time to speak with young people about financial literacy, including the fundamentals of saving and investing. He also gives presentations at senior centers, churches and to other community groups about financial scams and ways people can better recognize potential fraud.

Why Matt Griggs Chose LPL

Griggs selected LPL for independence, flexibility and freedom to shape his business around how he believes clients can best be served. In particular, he was attracted to having greater flexibility over his practice and its pricing while building a business designed around existing client relationships and organic growth.

“This move is about having the freedom to build a better business for my clients,” Griggs said. “This next chapter gives me greater flexibility to make decisions based on what I believe is right for the people I serve. My goal isn’t simply to build a bigger practice. It’s to build a better one, where I can stay focused on clients, continue strengthening those relationships and grow organically by doing good work for them.”

Marc Cohen, chief growth officer at LPL Financial, said, “Matt has built his practice around a simple but powerful idea: truly knowing the people he serves. His focus on understanding each client’s story, making financial concepts approachable and helping people feel more confident about their financial lives reflects the kind of relationship-driven advice we’re proud to support at LPL. We’re pleased to welcome Matt to LPL and look forward to giving him the flexibility and resources to build the practice he envisions while continuing to put clients at the center of his business.”

Related

Advisors, learn how LPL Financial can help take your business to the next level.

About LPL Financial

LPL Financial Holdings Inc. (Nasdaq: LPLA) is among the fastest growing wealth management firms in the U.S. As a leader in the financial advisor-mediated marketplace, LPL supports more than 32,000 financial advisors and the wealth management practices of approximately 1,100 financial institutions, servicing and custodying approximately $2.6 trillion in brokerage and advisory assets on behalf of approximately 8 million Americans. The firm provides a wide range of advisor affiliation models, investment solutions, fintech tools and practice management services, ensuring that advisors and institutions have the flexibility to choose the business model, services, and technology resources they need to run thriving businesses. For further information about LPL, please visit www.lpl.com.

Securities and advisory services offered through LPL Financial LLC (“LPL Financial”), a registered investment advisor and broker-dealer, member FINRA/SIPC. Griggs Investment Group and LPL Financial are separate entities.

Throughout this communication, the terms “financial advisors” and “advisors” are used to refer to registered representatives and/or investment advisor representatives affiliated with LPL Financial.

We routinely disclose information that may be important to shareholders in the “Investor Relations” or “Press Releases” section of our website.

*Value approximated based on asset and holding details provided to LPL from end of year, 2025.

Media Contact: 
Media.relations@LPLFinancial.com  

Tracking #1196820